2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
13
Obesity
6
Weight Loss
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Insulin Resistance
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Motor Activity
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Body Weight
1
Interventions
Radiotherapy
4
ferric carboxymaltose
3
Ropivacaine
3
Neoadjuvant Therapy
3
Exercise
3
Ultrasonography
2
Tranexamic Acid
2
Surgical Procedures, Operative
2
Standard of Care
2
Sodium Chloride
2
Sevoflurane
2
Psychiatric Rehabilitation
2
Propofol
2
Proctectomy
2
Preoperative Exercise
2
Oxaliplatin
2
Lymph Node Excision
2
Immunonutrition Diet
2
Hepatectomy
2
Fluorouracil
2
Fibrin Tissue Adhesive
2
Ethanol
2
Dexamethasone
2
Counseling
2
Colectomy
2
Blood Specimen Collection
2
Bevacizumab
2
vapreotide
1
streptococcal preparation 722
1
methyl N-acetylsibirosaminide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Postoperative Complications
×
Caloric Restriction
×
Clear all
NCT03676478
2025-12-10
EFECTS
University Hospital, Gasthuisberg
Phase NA
Terminated
239 enrolled